Medical Cannabis as the Source of Cryptococcus neoformans Infection.

Whole-genome sequencing demonstrated that Cryptococcus neoformans serotype A from cerebrospinal fluid and larynx of a patient receiving therapy for refractory multiple myeloma and from the patient's medical cannabis were indistinguishable. This is the first study to definitively link an infection to...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Infectious Diseases Vol. 81; no. 5; pp. 914 - 917
Autores principales: Kramer, Kailey Hughes, Marino, Christopher C, Driscoll, Eileen, Cheng, Shaoji, Phillips, Kaitlin, Volpe, Peter J, Clancy, Cornelius J, Nguyen, M Hong
Formato: case study tables/charts Journal Article
Publicado: Oxford University Press / USA 11/15/2025
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Whole-genome sequencing demonstrated that Cryptococcus neoformans serotype A from cerebrospinal fluid and larynx of a patient receiving therapy for refractory multiple myeloma and from the patient's medical cannabis were indistinguishable. This is the first study to definitively link an infection to a pathogen in medical cannabis used by a patient.